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- MRS was supplemented with phenylalanine or glycerol and fermented by 
Lactobacillus reuteri R29
- Accumulation of phenyllactic acid and reuterin was significantly increased
- Antifungal activity in vitro against common food spoilage fungi was 
significantly increased
- Antifungal performance of PLA was transferable in a bread system
- Antifungal activity of reuterin was not transferable in a bread system
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13 Lactic acid bacteria have shown great potential as bio-preservative agents to 
14 maintain high food quality and safety. The strain Lactobacillus reuteri R29 is reported 
15 to have a broad spectrum of antifungal activity and suitability for application in food 
16 systems. Its antifungal activity is predominantly based on phenyllactic acid (PLA). 
17 Furthermore, it is potentially a producer of reuterin, a potent antimicrobial agent. This 
18 study focused on increasing the antifungal activity in vitro by supplementation of the 
19 growth medium with phenylalanine and glycerol to increase the yield of PLA and 
20 reuterin, respectively. For PLA, the addition of 1.5% phenylalanine (w/v) to MRS, 
21 resulted in significantly increased accumulation of PLA and antifungal performance 
22 against Fusarium culmorum. Supplementation of MRS with 500mM glycerol 
23 combined with a reduced glucose content (1.5%) showed the highest reuterin 
24 accumulation combined with fungal inhibition. To investigate the antifungal 
25 performance in situ, these cell-free supernatants (cfs) were applied in a bread 
26 system. The application of PLA-enriched cfs resulted in significantly extended (4 
27 days) microbial shelf life compared to the control. The reuterin-enriched medium did 
28 not lead to significant shelf life extension. In conclusion, Lactobacillus reuteri R29 
29 and its PLA-enriched cfs were found to be very promising alternatives for food bio-
30 preservation. 





35 Lactic acid bacteria (LAB) are key microorganisms used for the production of various 
36 bakery products. They substantially improve nutritional and technological properties, 
37 as well as the flavour. However, current research is predominantly focused on their 
38 antimicrobial properties and potential applications as food bio-preservatives (Dalié, 
39 Deschamps, & Richard-Forget, 2010). The use of such LAB has the potential to 
40 replace chemical preservatives, such as calcium propionate, which would allow a 
41 “clean label” and hence lead to higher consumer acceptance (Pawlowska, Zannini, 
42 Coffey, & Arendt, 2012). In recent years, several strains of different genera have 
43 been found to express antimicrobial activity in vitro and in situ against food spoilage 
44 fungi (Axel et al., 2016; Crowley, Mahony, & Van Sinderen, 2013).
45 The antifungal activity of LAB is predominantly based on complex synergistic effects 
46 between several compounds. The production of these compounds is highly 
47 dependent on the strain and growth substrate. The exact interactions between the 
48 bacterial metabolites which create this synergistic effect are not yet fully understood. 
49 However, several metabolites that contribute to the antifungal activity have been 
50 identified and characterised. These metabolites, amongst others, include carboxylic 
51 acids (Ryan, Dal Bello, & Arendt, 2008) and 3-hydroxypropionaldehyde (3-HPA) also 
52 known as reuterin (Lüthi-Peng, Dileme, & Puhan, 2002).
53 Recently, the production and activity of 3-phenyllactic acid (PLA) has received great 
54 attention (Mu, Yu, Zhu, Zhang, & Jiang, 2012). This broad-spectrum antimicrobial 
55 compound originates in LAB fermented products from the catabolism of 
56 phenylalanine (Phe). Thereby, the Phe first undergoes a transamination by 
57 transferring the amino group onto a keto-acid acceptor. The synthesised 
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58 phenylpyruvic acid is then reduced to PLA by a dehydrogenase (Vermeulen, Gánzle, 
59 & Vogel, 2006). The antifungal activity of PLA is also dependent on a synergistic 
60 mechanism with other bacterial metabolites. Nevertheless, if the metabolic pathway 
61 yielding PLA is promoted, the antifungal activity is likely to increase. This could 
62 expand the field of application for LAB as bio-preservatives.
63 A very promising antimicrobial agent is the multicomponent system called reuterin, 
64 which results from the conversion of glycerol to 3-HPA (Engels et al., 2016). The 
65 antimicrobial activity of reuterin is, according to Schaefer et al. (2010), mainly based 
66 on its reactivity with free thiol groups of proteins, inducing oxidative stress in the 
67 target cells. It is understood that 3-HPA is released upon enzymatic dehydration of 
68 glycerol. Recent research conducted by Engels et al. (2016) suggests a rapid in situ 
69 conversion to acrolein, which is mainly responsible for the antimicrobial activity of the 
70 reuterin system. However, if sufficient amounts of carbohydrates, in particular 
71 glucose, are available, 3-HPA is further reduced to 1,3-propanediol which has no 
72 antimicrobial activity (Gänzle, 2015). Unfortunately, the research on reuterin so far 
73 has mainly focused on its industrial use as precursor for the synthesis of acrolein, 
74 not on food applications. To date, there are only two studies conducted by Gomez-
75 Torres et al. (2014) and Ortiz-Rivera et al. (2017) available, investigating a possible 
76 application of reuterin as an antibacterial agent in a food system. As Gänzle (2015) 
77 observed, the applicability of reuterin, particularly in heat treated food systems, 
78 remains unclear. Further research is required, in particular to elucidate the effect of 
79 glycerol on bacterial growth and reuterin production. 
80 A strain previously reported as demonstrating strong antifungal activity and suitability 
81 for food applications is Lactobacillus reuteri R29 (Axel et al., 2016; Oliveira et al., 
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82 2015). Oliveira et al. (2015) demonstrated that the cell-free supernatant (cfs) of 
83 medium fermented for 48 h with this strain showed antifungal activity against F. 
84 culmorum, with PLA being the predominant antimicrobial compound produced. As it 
85 belongs to the species L. reuteri, the strain is likely to be a reuterin producer. To date 
86 there have been no studies carried out investigating the ability of L. reuteri R29 to 
87 produce and accumulate reuterin. Thus, the enhancement of the production and 
88 accumulation of antifungal compounds, namely reuterin and PLA, in the bacterial cfs 
89 represents a promising opportunity in particular, if this antifungal activity is applicable 
90 in food systems.
91 Therefore, the aim of this study was to increase the in vitro antifungal activity of L. 
92 reuteri R29 cfs. Different variations of the fermentation medium composition were 
93 investigated to increase the accumulation of PLA and reuterin. F. culmorum was 
94 used as indicator mould to determine the antifungal activity in vitro. Secondly, 
95 characterisations regarding the heat stability of the most efficient cfs were evaluated. 
96 Finally, antifungal cfs delivering the best results were applied in the bread system to 
97 obtain information regarding suitability for application in a food matrix. This study 
98 provides important information regarding the potential of L. reuteri R29 cfs as 
99 antifungal agent and its application as a bio-preservative agent, in the bread system.
100 2 Materials and Methods
101 2.1 Materials
102 Ingredients for microbiological media, chemicals and analytical standards used in 
103 this study were at least analytical grade and obtained from Sigma-Aldrich (Dublin, 
104 Ireland), unless otherwise stated. The analytical standards had a purity of ≥95%.
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105 Wheat flour (bakers flour, Odlums, Dublin, Ireland), dry yeast (Puratos, Groot-
106 Bijgaarden, Belgium), salt (Glacia British Salt Limited, Cheshire, UK), commercially 
107 available sunflower oil, sodium stearoyl lactylate (SSL) (Danisco, Denmark) and 
108 ascorbic acid (Storefast solutions, UK) were used for the baking trials.
109 2.2 Cultures, media and growth conditions
110 Fusarium culmorum TMW4.2043, Aspergillus niger FST4.21, Penicillium expansum 
111 FST 4.22 originated from the culture collection of School of Food and Nutritional 
112 Sciences, University College Cork (Cork, Ireland). Fungal spore suspensions were 
113 prepared according to the method described by (Oliveira, Mauch, Jacob, Waters, & 
114 Arendt, 2012).
115 Lactobacillus reuteri R29, originally isolated from human intestine, was obtained from 
116 the UCC culture collection (School of Food and Nutritional Sciences, University 
117 College Cork, Cork, Ireland). For long term storage, the culture was kept in 
118 commercial de Man Rogosa and Sharpe (MRS) broth containing 40% glycerol at -
119 80°C. The culture was routinely refreshed on MRS agar plates (Fulka Chemie AG, 
120 Buchs, Switzerland) under anaerobic conditions at 37°C for 48 h.
121 2.3 Production of LAB cell-free supernatants
122 For production of 1-step fermented LAB cfs, a single colony, grown as described in 
123 2.2, was inoculated in 5 mL MRS broth for 24 h at 37°C. Subsequently, a 1% 
124 inoculum into fresh fermentation medium (Table 1 and 2) was prepared and 
125 incubated at 37°C for the designated time. After fermentation, cell cultures were 
126 centrifuged (5,000 g, 15 min, 4°C) and the supernatant was sterile filtered through a 
127 0.22 μm filter. The cfs obtained was stored at -20°C until further use.
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128 The 2-step fermentation process was based on the method described by Doleyres et 
129 al. (2005) with the following modifications. After the first fermentation step, cells were 
130 washed and resuspended in sterile distilled water, containing 400 mM glycerol, at a 
131 final concentration of 109 CFU/mL. The suspension was incubated for 2 h at 30°C 
132 and the cfs collected as described above.
133 2.4 Evaluation of in vitro antifungal activity and determination of minimal 
134 inhibitory concentration (MIC90)
135 Pre-trials were carried out to determine the ideal fungal spore concentration to 
136 investigate the increase of antifungal performance in the respective cell-free 
137 supernatants. Thereby, a concentration of 106 spores/mL as applied in the assay 
138 described were chosen for the subsequent experiments (data not shown). To 
139 determine the in vitro antifungal activity, 1 mL of Fusarium culmorum, Aspergillus 
140 niger or Penicillium expansum spore solution (containing approximately 106 spores) 
141 was transferred into a 2 mL microcentrifuge tube and centrifuged at 3,000 g (10 min, 
142 4°C). The supernatant was discarded and the spore pellet resuspended in 1.0 mL of 
143 diluted LAB cfs (10%, v/v, in unfermented MRS). Subsequently, 200 μL aliquots were 
144 pipetted into a 96-well microplate (Sarstedt AG and Co, Nurembrecht, Germany). To 
145 control for the effect of condensation, each supernatant was also inoculated with 1 
146 mL of sterile synthetic nutrient-poor bouillon, instead of fungal spore solution (blank). 
147 The microplate was sealed with an optically clear seal for Q-PCR (Thermo Scientific, 
148 Waltham, USA) and incubated in a Multiskan FC microplate-reader (Thermo 
149 Scientific, Waltham, USA) for 5 days at 25°C. The optical density was recorded at 
150 620 nm (OD620) every 2 h, with agitation in 4 s intervals. Values of each cfs 
151 inoculated with spore solution were corrected by the respective mediums blank 
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152 value. Antifungal activity was calculated as the percentage of OD reduction 
153 compared to the respective 0 h fermented medium and expressed as “percentage of 
154 growth inhibition”.
155 To determine the MIC90 of PLA the substance was added to unfermented MRS-broth 
156 to a final concentration of 20,000 ppm and the pH adjusted to match the fermented 
157 medium. Due to the lack of a commercially available standard for reuterin, a serial 
158 dilution of the 2-step fermented supernatant was used to determine the MIC90. The 
159 MIC90 was defined as the minimal concentration of the respective antifungal 
160 compound required to achieve at least 90% reduction of fungal growth after 120 h 
161 under the assay conditions compared to a control medium without the antifungal 
162 compound.2.5 Determination of antifungal fermentation products
163 2.5.1 Determination of carboxylic antifungal compounds
164 An Agilent 1260 high-performance liquid chromatography system equipped with an 
165 ultraviolet-diode array detector (UV/DAD) was used to quantify antifungal carboxylic 
166 compounds. Standard calibration curves for lactic and acetic acid (2 – 32 mM), as 
167 well as 13 phenolic compounds (catechol, hydroxyphenyllactic acid, 4-
168 hydroxybenzoic acid, hydrocaffeic acid, caffeic acid, phloretic acid, hydroferulic acid, 
169 p-coumaric acid, ferulic acid, benzoic acid, salicylic acid, hydrocinnamic acid, 
170 methylcinnamic acid, vanillic acid and 3-phenyllactic acid) were prepared, using five 
171 different concentrations in duplicate. Calibration curves showed good linearity with 
172 correlation coefficients of ≥0.999 for all compounds. Extraction of antifungal organic 
173 acids (acetic acid and lactic acid) was carried out as described by Axel et al. (2016). 
174 For separation of the acids a Hi-Plex H Column (300×7.7 mm, 8 μm; Agilent, Cork, 
175 Ireland), equipped with a guard column (50×7.7 mm, 8 μm; Agilent, Cork, Ireland) 
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176 was used. Setting the UV/DAD at 210 nm, lactic and acetic acids in the cfs were 
177 determined after elution with 0.004 M sulphuric acid at 65 °C with a flow of 0.5 
178 mL/min. Injection volume used was 20 μL.
179 Antifungal phenolic compounds were extracted, using a QuEChERS approach, as 
180 described by Peyer et al. (2016). Separation was carried out using a Gemini C18 
181 column (150 x 2.0 mm, 5 μm; Phenomenex, Macclesfield, UK), equipped with a 
182 guard column (AF0-8497; Phenomenex, Macclesfield, UK). The mobile phase 
183 consisted of A) H2O with 0.1% FA and B) ACN with 0.1% FA. To ensure separation 
184 from other compounds, a gradient flow was performed (0 – 5 min – 90% A, 30 min – 
185 80% A, 35 min – 60% A, 45 min – 5% A, 45 – 70 min – 90% A), using a flow rate of 
186 0.2 mL/min at a temperature of 30°C. The volume injected was 10 μL and detection 
187 carried out at a wavelength of 210 nm.
188 If necessary, samples were diluted prior to extraction to ensure peak areas were 
189 within the calibration range. Identity of the peaks evaluated in the cfs samples was 
190 confirmed as PLA by comparison of the UV/VIS spectrum with the standard solution. 
191 The limit of detection (LOD) and the limit of quantification (LOQ) were determined 
192 from the signal/ noise (s/n) ratio. The LOD was set for s/n of 3:1 and the LOQ was 
193 set for s/n of 10:1. Recovery rates of the phenolic compounds were done with 3.0 
194 mg/L of each analyte added in MRS and in chemically acidified MRS (pH 3 with 0.1 
195 N HCl), and ranged from 89.1% (hydrocinnamic acid) to 118.1% (vanillic acid) of the 
196 total spiked amount.
197 2.5.3 Colorimetric assay for reuterin quantification
198 The concentration of reuterin in the cfs of the 1- and 2-step fermentations was 
199 determined using the colorimetric assay described by Lüthi-Peng et al. (2002). 
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200 Calibration was carried out, using acrolein as standard in distilled water (0.1 – 6.0 
201 mM) and MRS broth (0.2 – 10 mM). Both calibration curves showed good linearity 
202 with correlation coefficients of >0.999.
203 2.6 Heat stability of antifungal fermentation products
204 Heat stability of the antifungal supernatants was determined by subjecting the cfs to 
205 100°C for 1 h. Subsequently, samples were cooled immediately and kept in the 
206 fridge until further use. Control samples (not heat treated) were kept in the fridge at 
207 all times. Analysis of in vitro antifungal activity and quantification of antifungal 
208 compounds was carried out as described in sections 2.4 and 2.5, respectively but 
209 only F. culmorum was used as indicator mould.
210 2.7 Application of cfs in bread system and shelf life analysis
211 For baking trials, water in the recipe was replaced by the respective LAB cell-free 
212 supernatant. For preparation of breads 63% cfs, 3% yeast, 3% oil, 2% salt, 0.5% 
213 SSL and 0.1% ascorbic acid (each based on flour weight) were used. Reactivation of 
214 the yeast and dough preparation was carried out according to Heitmann et al. 
215 (2015). The dough was then divided into 65 g portions, placed in non-stick baking 
216 tins (dimensions: top inside, 50 mm x 90 mm; bottom outside, 45 mm x 85 mm; 
217 inside depth, 30 mm; Sasa UK, Enfield Middlesex, UK) and proofed for 75 minutes 
218 (30°C, 85% RH). Doughs were transferred into the oven (MIWE, condo, Arnstein, 
219 Germany) and baked for 14 minutes at 210°C (top and bottom). Following baking the 
220 bread loaves were removed from the tins immediately and cooled to room 
221 temperature for at least 120 min before further use.
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222 The microbial shelf life test was carried out according to Heitmann et al. (2015). The 
223 amount of fungal spoilage was visually recorded over 13 days for each slice, using a 
224 calliper to determine the fungal colony size. Based on the percentage of the total 
225 surface area of the slice where fungal outgrowth occurred, each slice was 
226 categorised every day as A) mould-free, B) <10% covered with mould, C) 11 – 25% 
227 covered with mould, D) 26 – 50% covered with mould or E) >50% covered with 
228 mould.
229 2.8 Statistical analysis
230 Baking trials and all analyses were carried out from three independent fermentations, 
231 analysing each sample in duplicate. Statistical analysis was performed using Minitab 
232 17 software. Data points were checked for outliers (Grubb’s test) and evaluation of 
233 significant differences was performed using one-way analysis of variances (ANOVA). 
234 All differences were considered significant at P < 0.05. Where F-values were 
235 significant, pairwise comparisons were carried out with the help of Tuckey Post Hoc 
236 test to describe the statistical significance between the different fermentation media 
237 and times.
238 3 Results and Discussion
239 3.1 Effect of phenylalanine on antifungal activity and production of 
240 phenyllactic acid
241 Fungal isolates of F. culmorum, Aspergillus niger and Penicillium expansum were 
242 used as indicator moulds to evaluate the impact of Phe supplementation on the 
243 antifungal activity in vitro and PLA production. The results obtained are summarised 
244 in Table 1. The sole addition of up to 2% Phe (w/v) to MRS broth had no noteworthy 
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245 effect on the fungal growth in the unfermented medium (0 h fermentation). The PLA 
246 quantities for all 0 h fermented samples were below the limit of detection. Thus, all 
247 media used for inoculation of the different fungal spores were generally suitable for 
248 their growth and any inhibition obtained in the fermented samples was due to the 
249 antifungal metabolites produced by L. reuteri R29. Concentrations of antifungal 
250 carboxylic and phenolic acids were determined for all samples analysed. However, 
251 no significant differences (p < 0.05), apart from the PLA concentration, was found 
252 between any of the samples fermented for equal amounts of time (data not shown).
253 After 24 h of fermentation, all samples were found to contain substantial amounts of 
254 PLA. In addition, the PLA quantities were in direct correlation to the amount of Phe 
255 initially added. This confirms the findings of Rodríguez et al. (2012), that more PLA is 
256 produced when more Phe is available during fermentation. The PLA level of the 
257 unsupplemented MRS at this point (24 h) was 38.4±1.3 ppm. When challenged with 
258 the fungal spores (107 spores/mL) the antifungal activity of the cfs was relatively 
259 poor. After 120 h no noteworthy inhibition was detected against either of the three 
260 fungal isolates. The cfs obtained through fermentation of MRS+1.5% Phe and 
261 MRS+2% Phe resulted after 120 h of incubation in significantly (p < 0.05) better 
262 inhibition of fungal spore germination, compared to cfs produced from 
263 unsupplemented MRS. But, it needs to be mentioned that the supernatants 
264 presented stronger inhibition against F. culmorum than against A. niger and P. 
265 expansum. Hence, it can be concluded that F. culmorum is the most sensitive of the 
266 three fungal species towards PLA. Similarly, the concentration of PLA in the cfs was 
267 found to be 3 times higher compared to the control. Addition of 0.5% or 1.0% Phe 
268 was much less efficient in terms of PLA accumulation and antifungal activity.
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269 Finally, after 48 h of fermentation, all cfs showed the best spore germination 
270 inhibition for the respective medium. The fermentation of unsupplemented MRS 
271 resulted in limited inhibition of fungal spore germination over 120 h of incubation. 
272 Compared to the unfermented medium, spore inhibition rates of 18.4±1.4%, 
273 2.2±0.4% and 3.1±0.4% were found against F. culmorum, A. niger and P. expansum, 
274 respectively. In contrast, the addition of 1.0% Phe to the medium led to substantially 
275 improved antifungal activity (60.3±3.2%) over 120 h when challenged against F. 
276 culmorum. The most efficient medium composition, in terms of antifungal 
277 performance, was the addition of 1.5% Phe. This cfs resulted in 84.1±3.2% inhibition 
278 of spore germination against F. culmorum after 120 h. When challenged against the 
279 other fungal genera, spore germination inhibition was found to be less substantial, 
280 yet significantly increased compared to the unsupplemented medium. In contrast, the 
281 supplementation with higher amounts of Phe did not further improve the antifungal 
282 performance. The addition of less than 1.0% Phe showed no positive effect on the 
283 antifungal performance. In general, the quantities of PLA determined for each cfs 
284 correlate well with its respective antifungal activity. Thus, up to the addition of 1.5% 
285 Phe, the amounts of PLA increased in direct correlation with the level of Phe initially 
286 added. But no further increase could be achieved by supplementation with higher 
287 quantities of Phe. Furthermore, the concentration of PLA after 48 h of fermentation 
288 was always the highest for the respective medium, compared with shorter 
289 fermentation times. This also correlates with the findings of Oliveira et al. (2015) who 
290 concluded that PLA is produced by resting cells. The reason behind this is the 
291 promotion of amino acid metabolism under nitrogen poor conditions (Hazelwood, 
292 Daran, van Maris, Pronk, & Dickinson, 2008), which yields the antifungal carboxylic 
293 acids, like PLA. Thus, after consuming the majority of nitrogen during the initial 
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294 growth phase, the resting bacteria have to survive in a relatively nitrogen poor 
295 environment. This leads to increased catabolism of Phe and hence the high release 
296 of PLA.
297 Furthermore, it was evident that the antifungal activity of cfs obtained from L. reuteri 
298 R29 was clearly related to the amounts of PLA accumulated in the medium. For all 
299 supernatants tested, a significant increase in PLA yield also led to improved 
300 antifungal performance. These results are in correlation with previous findings of 
301 Oliveira et al. (2015), who reported the antimicrobial activity of PLA and its role as 
302 lead antifungal substance produced by Lactobacillus reuteri R29. Conversely, Axel et 
303 al. (2016) found that it is not necessarily the strain with the highest production of 
304 antifungal compounds that shows the best antifungal activity, demonstrating the key 
305 role of the type of the antifungal compounds and their synergistic effects. 
306 Nevertheless, the increased accumulation of antifungal active compounds by L. 
307 reuteri R29 improves the overall antifungal performance of this particular strain 
308 (Valerio, Di Biase, Lattanzio, & Lavermicocca, 2016). Thus, the increased 
309 accumulation of PLA, as the lead antifungal compound of L. reuteri R29, led to 
310 improved antifungal activity of the cfs. This clearly demonstrates the great potential 
311 of microbial produced PLA as an antifungal substance.
312 It has to be mentioned however, that MIC90 values of synthetic PLA in acidified MRS 
313 against all three fungi tested are more than 10 times higher compared to the 
314 amounts detected in the bacterial supernatants showing fungal inhibition. MIC90 
315 values determined are 6,000 ppm against F. culmorum and 15,000 ppm against A. 
316 niger and P. expansum (data not shown). Considering the high concentration of 107 
317 fungal spores/mL these values are in good correlation with the findings of 
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318 Lavermicocca, Valerio, & Visconti (2003). After all, these findings highlight that PLA, 
319 although being of major importance for antifungal performance, is not the only 
320 component responsible. Instead the synergy of PLA with other bacterial metabolites 
321 resulting in antifungal performance is evident.
322 In conclusion, the addition of Phe to the bacterial growth medium resulted in a 
323 supernatant which exhibited improved antifungal activity in vitro against fungal 
324 spores belonging to the genera of Fusarium, Aspergillus and Penicillium. This effect 
325 was clearly related to the higher PLA accumulation during LAB fermentation. The 
326 capacity to transfer this functionality to a food system remains unclear and will be 
327 investigated further in sections 3.3 and 3.4. This would allow the exploitation of the 
328 antifungal nature of LAB, particularly in systems that are unsuitable for direct 
329 bacterial fermentation. Thus, these results highlight novel and promising 
330 perspectives for the use of LAB as bio-preservatives.
331 As the 48 h fermentation of MRS broth supplemented with 1.5% phenylalanine was 
332 found to be the best antifungal medium, it was carried forward for further 
333 investigation, as discussed in sections 3.3 and 3.4. The medium and supernatant will 
334 henceforth be referred to as PMRS and Pcfs, respectively.
335 3.2 Effect of glycerol and sugar content on antifungal activity and reuterin 
336 production
337 Another promising antimicrobial compound with possible application in food systems 
338 and produced by certain strains of Lactobacillus reuteri, is the multicomponent 
339 system reuterin, with 3-hydroxy propionaldehyde (3-HPA) being the main active 
340 component. However, to date no study has demonstrated the ability of Lactobacillus 
341 reuteri R29 to produce reuterin via the bioconversion of glycerol. Various 
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342 combinations of glycerol and glucose in the growth medium were tested, in order to 
343 achieve the highest possible reuterin yield and the best antifungal activity in vitro 
344 against F. culmorum. Results for the different cfs, fermented for 0, 24 and 48 h, 
345 respectively are summarised in Table 2.
346 Firstly, the results show that all the unfermented media (0 h fermentation) provide a 
347 suitable substrate for spore germination of F. culmorum. The growth curve obtained 
348 for each respective medium was used as reference, in order to evaluate the 
349 antifungal activity of the respective fermentation cfs. Furthermore, concentrations of 
350 antifungal carboxylic and phenolic acids were determined for all samples, showing 
351 no substantial differences between any of the 24 and 48 h fermented samples were 
352 found.
353 After 24 h of fermentation, the cfs obtained from unmodified MRS contained no 
354 detectable amounts of reuterin, as MRS broth contains no glycerol. However, MRS 
355 supplemented with 250 – 1000 mM glycerol and a glucose content of 1.0 – 1.5% led 
356 to cfs containing various concentrations of reuterin. Values determined ranged 
357 between 12.5±0.1 mM (250 mM glycerol, 1.0% glucose) and 27.5±0.6 mM (500 mM 
358 glycerol, 1.5% glucose). Any further increase of glucose in the medium resulted in 
359 significantly lower reuterin concentrations, as the data for the media containing 2% 
360 glucose (Table 2) demonstrate. This suggests that 1.5% glucose in the initial 
361 medium is the ideal amount required for L. reuteri R29 to accumulate reuterin. At this 
362 level of glucose, the bacteria are able to grow to high cell density in the medium, 
363 resulting in a high glycerol conversion to reuterin. However, this concentration is low 
364 enough to avoid expression of the 3-HPA reductase responsible for the reductive 
365 effect on antifungal activity by removing reuterin from the system through its 
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366 conversion to 1,3-propanediol. Comparison of reuterin contents for media containing 
367 similar amounts of glycerol but varying glucose contents suggests that in presence of 
368 sufficient amounts of glucose the 3-HPA reductase is expressed already during the 
369 first 24 h of fermentation, preventing the accumulation of reuterin. The ideal amount 
370 of added glycerol was found to be 500 mM, as it resulted in the highest reuterin 
371 concentrations for each respective level of glucose in the medium. The amount of 
372 reuterin produced by L. reuteri R29 correlates well with the in vitro antifungal activity 
373 against fungal spores of F. culmorum, A. niger and P. expansum. As mentioned in 
374 section 3.1 the cfs obtained from normal MRS broth showed, due to the high spore 
375 concentration, very low levels of inhibition against the three fungi after 120 h of 
376 incubation. In contrast, the supernatants containing reuterin presented substantially 
377 better spore germination inhibition, demonstrating the antifungal potential of reuterin. 
378 The cfs with the highest reuterin concentration (500 mM glycerol, 1.5% glucose) 
379 showed total inhibition of F. culmorum against 107 spores/mL over 96 h of incubation 
380 (data not shown), and, after 120 h still had 69±2% fungal inhibition. Similarly to the 
381 Pcfs, inhibition of Aspergillus and Penicillium spores was found to be less substantial 
382 but still significant compared to the control (unsupplemented MRS). In conclusion, it 
383 is evident from these results that a higher reuterin concentration results in enhanced 
384 antifungal performance of the cfs. 
385 In contrast, after 48 h of fermentation, the amounts of reuterin and the antifungal 
386 performance for each supernatant decreased substantially, compared to the 
387 respective 24 h fermented medium. This may be due to the extremely high reactivity 
388 of reuterin. As MRS broth is a complex medium, it provides plenty of potential 
389 reaction opportunities for reuterin. Furthermore, if the fermentation time is too long 
390 the reuterin acts as a self-inhibiting antimicrobial compound against the LAB in the 
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391 medium (Lüthi-Peng et al., 2002). Although L. reuteri R29 was shown to be able to 
392 produce and accumulate reuterin, exact control of the fermentation parameters, such 
393 as time and medium composition is crucial. As a consequence, cfs obtained after 48 
394 h of fermentation showed no significant difference in antifungal performance 
395 compared to the unsupplemented control.
396 Overall, the most efficient modification in terms of reuterin yield and in vitro 
397 antifungal activity against F. culmorum was obtained by 24 h fermentation of MRS 
398 supplemented with 500 mM glycerol and 1.5% glucose, instead of the conventional 
399 2% glucose. This concentration appears to be the best compromise to allow 
400 sufficient bacterial growth and at the same time inhibit the expression of 3-HPA 
401 reductase. This correlates well with the findings of Lüthi-Peng et al. (2002). 
402 Consequently, the modification of the bacterial growth medium to induce reuterin 
403 production and accumulation was shown to be a promising method of improving the 
404 suitability of L. reuteri R29 as a bio-preservative agent.
405 In addition, the possibility of a combined increase in PLA and reuterin accumulation 
406 during LAB fermentation was attempted. However, this resulted in a total loss of 
407 antifungal activity (data not shown) of the cfs, due to the high reactivity of reuterin 
408 with the free amino-group of the Phe, needed as pre-cursor for PLA (Hazelwood et 
409 al., 2008).
410 As reuterin has industrial relevance as pre-cursor for the production of acrolein, 
411 several studies have been conducted to increase the reuterin production by LAB. 
412 These studies solved the problem regarding the carbohydrate content by application 
413 of a 2-step fermentation process. Although this process leads to high reuterin 
414 accumulation, with the cfs of the first fermentation step, also antifungal compounds 
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415 produced by L. reuteri R29 are removed. Thus, it is uncertain if this process 
416 ultimately leads to effective fungal inhibition when applied in vitro. Therefore, the 2-
417 step fermentation method of Doleyres et al. (2005) was adopted and tested for both, 
418 yield of reuterin and in vitro antifungal activity. Here, a reuterin content of up to 
419 93.1±2.0 mM was achieved. Although this is much lower than the previously reported 
420 176 mM (Doleyres et al., 2005) it equates to a more than 3 fold increase compared 
421 to the yield in the 1 step fermentation procedure (27.5±0.6 mM). This relatively low 
422 level of reuterin, compared to Doleyres et al. (2005), is most likely due to the use of a 
423 different strain of Lactobacillus reuteri. When the cfs was applied in vitro in the 
424 antifungal assay, it resulted in a total inhibition of all fungi tested over 120 h of 
425 incubation. Consequently, the significantly increased yield of reuterin in the 2-step 
426 fermentation method fully compensated for the loss of carboxylic acids. In fact, the 
427 cfs produced by this method had the highest in vitro antifungal activity of all the 
428 treatments investigated in this study.
429 This 2-step fermented supernatant was further used to determine the MIC90 of 
430 reuterin, as no commercial reuterin standards are available. Values found were 4 
431 mM against F. culmorum and 8 mM against A. niger and P. expansum (data not 
432 shown). These values are in good correlation with the findings of Chung, Axelsson, 
433 Lindgren, & Dobrogosz (1989). Furthermore, it highlights the great potential of 
434 reuterin as antimicrobial and antifungal agent.
435 In conclusion, Lactobacillus reuteri R29 was shown to have the ability to metabolise 
436 glycerol to reuterin. This can be achieved using a 1 or 2 step fermentation 
437 procedure. Both approaches resulted in very high rates of fungal inhibition, when 
438 challenged against 107 spores/mL over 120 h (Table 2). Thus, the modification of the 
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439 fermentation process of L. reuteri R29 towards the production of reuterin shows the 
440 potential for bio-preservation. But the need to control parameters such as glucose 
441 and glycerol content, and fermentation time carefully, to allow accumulation of 
442 reuterin has to be kept in mind. For a successful application in a food system, the 
443 high reactivity of reuterin might impose further challenges. This applies in particular, 
444 if heat treatment is involved, as this would further increase the reactivity of reuterin. 
445 Furthermore, there is the risk of acrolein formation due to thermal dehydration 
446 (Gänzle, 2015). 
447 3.3 Heat stability of PLA and reuterin 
448 In order to get a more detailed picture with respect to the possible applications of the 
449 various antifungal cell-free supernatants obtained in sections 3.1 and 3.2, three 
450 selected media were subjected to heat treatment. In particular for use in food 
451 systems, a certain heat resistance would broaden the range of  possible applications 
452 immensely. Therefore, the impact of heat treatment (1 h at 100°C) on PLA and 
453 reuterin content, and on the antifungal performance in vitro was determined, using F. 
454 culmorum as indication strain.
455 For the Pcfs, no significant reduction of inhibitory capacity against F. culmorum was 
456 found. Even after 120 h the heat treated supernatant resulted in 80±3% of fungal 
457 growth inhibition, compared to 84±3% for the not heat treated cfs (Figure 1A). 
458 Chromatographic analysis of the heat treated supernatant further revealed no 
459 substantial loss in PLA, compared to the unheated one (data not shown). 
460 Consequently, this cfs can be considered as heat stable with regards to the 
461 antifungal performance and the concentration of its lead antifungal substance, PLA. 
462 This result is in good correlation with the findings of Cortés-Zavaleta, López-Malo, 
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463 Hernández-Mendoza, & García (2014). Thus, the fermentation of Phe enriched 
464 medium by L. reuteri R29 appears to be very promising for the production of 
465 antifungal cfs and use as a bio-preservative in food systems. 
466 For the reuterin-containing supernatants different results were obtained, depending 
467 on the fermentation method. For the cfs produced with the 2-step fermentation 
468 procedure, no substantial reduction in antifungal performance (Figure 1B) or reuterin 
469 content (Figure 1C) was observed. However, heat treatment of the cfs produced by 
470 the 1-step fermentation procedure resulted in a complete loss of antifungal activity 
471 (Figure 1D). Likewise, the concentration of reuterin in the cfs decreased from 
472 27.5±0.6 mM to 0.5±0.1 mM, due to the heating process (Figure 1C). The reason for 
473 these differences is in the constituents of the respective supernatant, as heating 
474 primarily increases the reactivity of reuterin (Vollenweider, Evers, Zurbriggen, & 
475 Lacroix, 2010). The 2-step fermentation produces a cfs that consists only of water, 
476 glycerol and reuterin, and thus no adequate reactive partner is present to sequester 
477 reuterin. Hence, the antifungal activity of this cfs was not notably effected by the 
478 heating process. On the other hand, the 1-step fermentation produces a supernatant, 
479 containing all the ingredients of MRS broth and several metabolites produced by the 
480 bacteria which are potential reactive partners for the reuterin. Consequently, the 
481 increase in reactivity due to heating resulted in a substantial decrease in reuterin 
482 content and hence severely reduced antifungal activity.
483 To examine this topic further and evaluate the antifungal activity in situ, the reuterin 
484 enriched (1- and 2-step fermentation process) and the Pcfs were applied into a 




487 3.4 Effect of PLA and reuterin on bread microbial shelf life
488 In order to investigate the antifungal activity in situ, it was attempted to transfer and 
489 exploit the increased antifungal activity (in vitro) in the food processing chain, using 
490 bread making as an example. Therefore, the water in the dough preparation was 
491 replaced with the cell-free supernatants and the effect on microbial shelf life was 
492 tested by challenge against environmental fungi. Thus, use of the in vitro fermented 
493 cfs enabled comparison of the in situ antifungal performance of the different 
494 supernatants without the influence of other ingredients on the bacterial growth.
495 As demonstrated in previous studies the application of LAB fermented media into a 
496 cereal food matrix is possible (Le Lay et al., 2016; Peyer et al., 2016; Russo et al., 
497 2015; Saladino et al., 2016). Furthermore, the routinely use of LAB as starter 
498 cultures for sourdough bread shows that the acidity has no substantial negative 
499 impact on the product quality and taste (Pawlowska et al., 2012). Hence, application 
500 of bacterial cfs, despite the strong acidic pH, as promising perspective for natural 
501 extension of microbial shelf-life.
502 As shown in Figure 2A, the use of cfs obtained by fermentation of normal MRS (24 
503 h) resulted in a microbial shelf life of 5 days. After 13 days of storage 83% of the 
504 bread slices contained mould colonies (category B), whereas the remaining 17% 
505 were still completely mould free. A very similar result was achieved for the same 
506 medium, fermented for 48 h (Figure 2B). The microbial shelf life was determined to 4 
507 days and after 13 days of storage 17% of the slices were still mould free. However, 
508 the mould was found to spread slightly faster, than with the 24 h fermented 
509 supernatant, as there were 6.5% of the slices in the “C” category (11 – 24% mouldy) 
510 and the rest in “B”. This outcome is interesting, as the antifungal activity in vitro was 
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511 evident after 48 h of fermentation. However, as the breads were challenged against 
512 environmental fungi and not just one specific strain, variations in the antifungal 
513 performance are possible. In particular, as the antifungal performance is based on a 
514 synergistic mechanism, the amount of organic acids produced cannot serve as sole 
515 indicator for antifungal activity. Thus, it is possible that the mixture of antifungal 
516 compounds present after 24 h is more effective against certain environmental fungi 
517 than after 48 h. These samples, served as controls in order to evaluate if the 
518 increased antifungal activity as evident in in vitro trials could also translated in situ.
519 In comparison, the Pcfs (24 h, Figure 2C) did not significantly increase the shelf life, 
520 compared to the respective control (MRS/24 h). The microbial shelf life was 
521 determined to be 5 days and after 13 days, 19% of the slices were still mould free. At 
522 the same time, 6.5% of the slices were mouldy to more than 10%. These differences 
523 to the 24 h fermented control are not statistically significant (p<0.05). Thus, the 24 h 
524 fermentation of Phe enriched MRS did not increase the antifungal performance in 
525 situ. In contrast, after 48 h of fermentation, the Pcfs led to substantially increased 
526 shelf life (Figure 2D) when compared to the respective control. The shelf life 
527 increased from 4 to 8 days (100%), due to the use of Pcfs. In addition, the spread of 
528 fungal outgrowth was found to be notably retarded and the number of mouldy slices 
529 after 13 days of monitoring was, with 53%, significantly reduced also. This correlates 
530 well with the results of the in vitro assays for the Pcfs against F. culmorum. These 
531 results strengthen the conclusions previously made by Crowley et al. (2013), who 
532 reported that LAB are, due to their antimicrobial acids, very promising candidates as 
533 food bio-preservatives. In addition, this result demonstrates the broad antifungal 
534 activity of PLA against various spoilage organisms in situ. Thus, the results obtained 
535 in this study further prove the suitability of L. reuteri R29 as natural food 
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536 preservative, using bread making as an example of such an application. The use of 
537 L. reuteri R29 as bio-preservative, in particular with emphasis on high PLA 
538 production appears to be a promising alternative to conventional preservatives.
539 Despite showing less promising results in vitro after heat treatment, the reuterin 
540 containing 1- and 2-step fermentations were also applied in the baking process. The 
541 respective 24 h and 48 h 1-step fermented supernatants (Figures 2E and F, 
542 respectively) were found to result in a shelf life increase of 1 day, compared to their 
543 respective controls. Also the spread of the fungal outgrowth appeared to be slower. 
544 However, these improvements were not statistically significant (p<0.05). Due to the 
545 high reactivity of reuterin, in particular at high temperatures as shown in section 3.3, 
546 it is likely that the reuterin reacted with other dough constituents. Thus, when the 
547 microbial challenge test was carried out, no noteworthy levels of active reuterin were 
548 present. This indicates that the breads obtained from this supernatant should 
549 perform similar to the control in terms of microbial shelf life, as the normally 
550 produced antifungal acids were present in both control and 1-step fermentation. 
551 Hence, the outcome of the shelf life test, where no significant difference to the 
552 control was found, is in good correlation with the previous results, as discussed in 
553 section 3.3. 
554 Finally, the 2-step fermented cfs showed the least antifungal activity of all samples, 
555 when applied to the baking process (Figure 2G). The shelf life decreased 
556 substantially by 2 days, compared to the 24 h MRS control. The fungal spread was 
557 also much faster than in any other sample, resulting in 42% of the bread slices being 
558 covered to more than 50% by fungi (category “E”), after 13 days of monitoring. Thus, 
559 the cfs obtained from the 2-step fermentation was found to be completely unsuitable 
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560 for in situ microbial preservation in bread. The explanation for this, again, is related 
561 to the high reactivity of reuterin, in particular at high temperatures. Although this 
562 supernatant showed heat stability when tested in vitro, the dough matrix is very 
563 complex and thus provides plenty of reaction opportunities for the reuterin. In 
564 particular, free thiol groups which are the main target in the inactivated microbes 
565 present in the flour can interfere with the reuterins antimicrobial performance. 
566 Despite the fact that levels of free thiol groups in a dough formulation as it was used 
567 here are 10 – 100 times below the reuterin concentrations (Kohler, 2003; Reinbold, 
568 Rychlik, Asam, Wieser, & Koehler, 2008) they are likely to compromise the antifungal 
569 activity significantly (Engels et al., 2016). Furthermore, the production process of this 
570 cfs eliminates the other metabolites produced by L. reuteri R29, such as antifungal 
571 acids. As a consequence, by losing the reuterin due to reactions with other dough 
572 constituents, no active antifungal compounds were present anymore. Hence, the 
573 outcome of an even further decreased shelf life, compared to the control. The results 
574 of this study clearly demonstrate that reuterin is not suitable as food preservative if it 
575 is subjected to heating. However, it may still be suitable for unheated foods like 
576 salami or cheese, for which it has already been successfully applied (Gomez-Torres 
577 et al., 2014; Ortiz-Rivera et al., 2017).
578 4. CONCLUSIONS
579 In conclusion, this study demonstrates three possibilities for improving the efficiency 
580 of antifungal LAB in vitro, using Lactobacillus reuteri R29 as an example. Further 
581 understanding regarding production and stability of antifungal compounds was 
582 obtained. In particular, the key role of PLA for the antifungal performance of L. reuteri 
583 R29 became evident. However, from the MIC90 values of synthetic PLA it also 
ACCEPTED MANUSCRIPT
26
584 became evident that microbial PLA just in synergy with other bacterial metabolites 
585 can serve as efficient antifungal agent. The results achieved in vitro, could only partly 
586 be transferred into the bread making process. Reuterin, due to its high reactivity, in 
587 particular at high temperatures (Vollenweider et al., 2010), did not lead to 
588 satisfactory results in situ. In contrast, the supplementation with Phe, to increase the 
589 production of PLA, was found to be very efficient in both in vitro and in situ. Hence, 
590 Phe supplemented fermentation media should be considered as promising options to 
591 improve the antimicrobial performance of LAB during production of food, such as 
592 bread or beverages. The proteolytic activity reported for L. reuteri R29 (Axel et al., 
593 2016) also proposes the possibility to achieve this antifungal effect upon 
594 supplementation with Phe rich proteins. This work shows the potential for further 
595 exploitation of LAB as bio-preservatives, particularly in environments unsuitable for 
596 bacterial fermentation, for example, during grain storage. This demonstrates the 
597 potential to enlarge the field of application for the antimicrobial properties of LAB. 
598 Further research is required on the in situ production of PLA, including its stability 
599 and influence on sensory parameters. In addition, application of such methodologies 
600 investigated in this study in further food systems will serve to increase our 
601 knowledge in this increasingly pertinent area.
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726 Table 1: Concentration (ppm) of phenyllactic acid (PLA) and antifungal activity over 120 h (% of growth inhibition) of cell-free supernatants of 
727 Lactobacillus reuteri R29 grown in MRS for 0, 24 or 48 h at 37°C in presence of various amounts of phenylalanine.#
antifungal activity after 120 hours of incubation [% growth inhibition against 107 spores/mL]
Medium fermentation time [h] PLA [ppm]
P. expansum A. niger F. culmorum
0 -a -a -a -a
24 38.4±1.3b 1.2±0.2b 0.2±0.1a 1.5±0.2MRS
48 85.3 ±1.1 3.1±0.4c 2.2±0.4b 18.4±1.4c
0 -a -a -a -a
24 41.6±1.8b 1.4±0.1b 3.2±0.5bc 3.4±2.2bcMRS + 0.5% Phe
48 103.2±2.3 3.6±0.3c 3.7±1.4c 14.1±2.8c
0 -a -a -a -a
24 57.5±1.5 2.2±0.3 2.8±1.4b 6.1±2.5cMRS + 1.0% Phe
48 237.1±1.4 16.5±1.3 24.7±3.7 50.3±3.2
0 -a -a -a -a
24 116.4±1.3c 8.3±0.8 11.0±0.5 25.4±3.1dMRS + 1.5% Phe
48 361.2±2.4d 32.7±0.2d 63.5±2.1d 84.1±3.2e
0 -a -a -a -a
24 113,2±1.8c 14.1±2.5 16.0±1.1 27.1±2.1dMRS + 2.0% Phe
48 363.8±2.0d 33.1±0.6d 62.9±1.6d 83.5±2.2e
728 # Results shown are mean values ± confidence interval. Values in one column followed by the same lower case letter are not significantly different, values 
729 without letter of significance are significantly different from all other values in the same column (p<0.05)
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730 Table 2: Concentration of reuterin (mM) and antifungal activity (% growth inhibition) against 
731 Penicillium expansum, Aspergillus niger and Fusarium culmorum of cell-free supernatants of 
732 Lactobacillus reuteri R29 grown in various MRS formulations, containing 1.0 – 2.0% of glucose 
733 and 250 – 1000mM of glycerol, for 0, 24 and 48h (1-step fermentation process) and for the 2-
734 step fermentation process (2h in water/glycerol).#
antifungal activity [% growth inhibition against 107 F. culmorum 
spores/mL]
Medium 






P. expansum A. niger F. culmorum
0 -a -a -a -a
24 -a 0.2±0.1 0.5±0.1b 0.3±0.2aControl (MRS)
48 -a 3.1±0.7b 8.2±0.4c 18.4±1.4b
0 -a -a -a -a
24 12.5±0.1 18.3±1.7d 22.5±0.2d 39.5±2.7
MRS + 250mM 
glycerol; 1.0% 
glucose
48 -a 2.1±0.4b 8.9±0.6c 8.4±1.2c
0 -a -a -a -a
24 20.5±1.1b 17.0±1.2d 24.5±1.3d 55.8±3.1d
MRS + 250mM 
glycerol; 1.5% 
glucose
48 0.4±0.1 3.5±0.4b 3.5±0.6e 8.7±2.1c
0 -a -a -a -a
24 0.9±0.2 4.5±0.2e 11.1±1.9f 15.7±2.6e
MRS + 250mM 
glycerol; 2% 
glucose
48 -a 2.2±0.3b 1.8±0.5 14.6±0.1e
0 -a -a -a -a
24 18.6±0.3 35.6±1.6 21.8±0.1d 58.7±2.3d
MRS + 500mM 
glycerol; 1.0% 
glucose
48 0.2±0.1a 2.4±0.2b 3.3±0.3e 8.8±0.6c
0 -a -a -a -a
24 27.5±0.6c 55.0±2.1 64.9±1.8 69.1±0.4
MRS + 500mM 
glycerol; 1.5% 
glucose
48 1.2±0.3d 3.1±1.1b 4.5±0.4e 17.9±2.1be
0 -a -a -a -a
24 1.3±0.2d 8.4±0.5 7.6±0.9 19.1±1.5e
MRS + 500mM 
glycerol; 2% 
glucose
48 -a 2.8±0.7b 2.2±0.5g 16.3±0.4e
0 -a -a -a -a
24 21.5±1.4b 14.7±1.0 13.4±0.2f 57.1±0.5d
MRS + 1000mM 
glycerol; 1.0% 
glucose
48 0.3±0.1a -a 0.2±0.1b -a
0 -a -a -a -a
24 26.6±0.3c 26.5±1.1 28.5±1.5d 52.9±2.4d
MRS + 1000mM 
glycerol; 1.5% 
glucose
48 0.5±0.4a 1.0±0.1c 1.4±0.2h 18.6±1.9be
0 -a -a -a -a
24 1.4±0.1d 3.6±0.7e 2.6±0.1g 18.1±1.6be
MRS + 1000mM 
glycerol; 2% 
glucose
48 -a 0.8±0.2c 1.2±0.2h 17.5±1.2be








[mM] P. expansum A. niger F. culmorum
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0 (control) -a -a -a -adistilled water + 
400mM glycerol 2 (sample) 93.1±2.0 100±0 100±0 100±0
735 # Results shown are mean values ± confidence interval. Values in one column followed by the same 
736 lower case letter are not significantly different, values without letter of significance are significantly 




739 Figure 1: In vitro antifungal activity against F. culmorum in A) MRS + 1.5% Phe (48h 
740 fermented), B) 2-step fermentation supernatant, C) impact of heat treatment on 
741 reuterin content of the cell-free supernatants and D) MRS + 500mM glycerol; 1.5% 
742 glucose (24h fermented).
743 Figure 2: Shelf life of wheat bread against environmental mould during a 13-day 
744 storage period is indicated as the percentage of the total surface area of each slice, 
745 where fungal growth occurred. Mould-free slices (A), <10% mouldy (B), 10-24% 
746 mouldy (C), 25-49% mouldy (D) and >50% mouldy (E). Mean values are shown 
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MRS+500mM glycerol, 1.5% glucose
MRS+500gly, 1.5% glu MRS+500gly, 1.5% glu heated
R29+500gly, 1.5% glu R29+500gly, 1.5% glu heated
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